IL6 and systemic sclerosis: The immunopathogenic mechanisms driving both skin fibrosis, ILD, and PH in SSc involve the same several key cytokines, chemokines, and cellular pathways, including transforming growth factor beta, interleukin-6, and interleukin-4.